Carisma Therapeutics Inc

NASDAQ:CARM   4:00:00 PM EDT
0.31
-0.02 (-6.63%)
7:58:30 PM EDT: $0.32 0.00 (0.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Carisma Therapeutics Inc Stock, NASDAQ:CARM

3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104
United States of America
Phone: +1.617.444.8550
Number of Employees: 107

Description

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.